These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 3698013

  • 1. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
    Mauldin SK, Husain I, Sancar A, Chaney SG.
    Cancer Res; 1986 Jun; 46(6):2876-82. PubMed ID: 3698013
    [Abstract] [Full Text] [Related]

  • 2. Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line.
    Mauldin SK, Gibbons G, Wyrick SD, Chaney SG.
    Cancer Res; 1988 Sep 15; 48(18):5136-44. PubMed ID: 3409241
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y, Khokhar AR, al-Baker S, Siddik ZH.
    Cancer Res; 1993 Oct 01; 53(19):4567-72. PubMed ID: 8402629
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M, Khokhar AR, Siddik ZH.
    Cancer Res; 1994 Sep 01; 54(17):4691-7. PubMed ID: 8062266
    [Abstract] [Full Text] [Related]

  • 7. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH, al-Baker S, Thai G, Khokhar AR.
    Anticancer Drug Des; 1994 Apr 01; 9(2):139-51. PubMed ID: 8166929
    [Abstract] [Full Text] [Related]

  • 8. An unexpected biotransformation pathway for tetrachloro-(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in the L1210 cell line.
    Chaney SG, Gibbons GR, Wyrick SD, Podhasky P.
    Cancer Res; 1991 Feb 01; 51(3):969-73. PubMed ID: 1988140
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of nucleic acid synthesis in P388 lymphocytic leukemia cells in culture by cis-platinum derivatives.
    Oswald CB, Chaney SG, Hall IH.
    Biomed Biochim Acta; 1990 Feb 01; 49(7):579-87. PubMed ID: 1704216
    [Abstract] [Full Text] [Related]

  • 10. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.
    Gibbons GR, Kaufmann WK, Chaney SG.
    Carcinogenesis; 1991 Dec 01; 12(12):2253-7. PubMed ID: 1747924
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.
    Farrell N, Kelland LR, Roberts JD, Van Beusichem M.
    Cancer Res; 1992 Sep 15; 52(18):5065-72. PubMed ID: 1516063
    [Abstract] [Full Text] [Related]

  • 13. Rapid reduction of tetrachloro(D,L-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in RPMI 1640 tissue culture medium.
    Gibbons GR, Wyrick S, Chaney SG.
    Cancer Res; 1989 Mar 15; 49(6):1402-7. PubMed ID: 2924297
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the effectivity of two diaminocyclohexane Pt-complexes.
    Balázová E, Hrubisko M, Ujházy V.
    Neoplasma; 1985 Mar 15; 32(5):537-42. PubMed ID: 4069288
    [Abstract] [Full Text] [Related]

  • 16. The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand (review).
    Chaney S.
    Int J Oncol; 1995 Jun 15; 6(6):1291-305. PubMed ID: 21556672
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells.
    Micetich KC, Barnes D, Erickson LC.
    Cancer Res; 1985 Sep 15; 45(9):4043-7. PubMed ID: 3896476
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ, Friedlos F, Lydall DA, Roberts JJ.
    Cancer Res; 1986 Apr 15; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.
    Yamashita T, Hirose J, Noji M, Saito R, Tomida H, Kidani Y.
    Biol Pharm Bull; 1993 Oct 15; 16(10):1014-8. PubMed ID: 8287030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.